10.1 Ordering, Acquisition & Distribution Records

Ordering, Acquisition & Distribution Records

New York overlays two separate regulatory tracks onto the ordinary drug supply chain: the New York State Education Department (NYSED) Board of Pharmacy, which licenses pharmacists and registers pharmacy and wholesaler establishments under Education Law Article 137, and the Department of Health (DOH) Bureau of Narcotic Enforcement (BNE), which separately licenses controlled-substance activity under Public Health Law (PHL) Article 33 and 10 NYCRR Part 80. A pharmacy's ordering and acquisition records must satisfy both tracks, and the MPJE Pharmacy Operations domain expects you to know which agency governs which record.

Federal Ordering Forms (Brief Cross-Reference)

Schedule II ordering still runs on the federal rails covered in this guide's Controlled Substances Act chapter: a DEA Form 222 (paper, triplicate) or an electronic order through the Controlled Substance Ordering System (CSOS) for Schedule II purchases, and an ordinary invoice bearing the supplier's DEA registration number for Schedules III–V. At the New York establishment level, the pharmacist-in-charge (PIC) is responsible for making sure Copy 3 of every DEA 222 (or its CSOS equivalent) is filed with the matching receiving invoice and is producible as a single audit trail on inspection — DOH and NYSED inspectors expect to see the order form and the receiving invoice together, not filed separately.

NY Establishment-Level Recordkeeping — 8 NYCRR §63.6

New York's own pharmacy practice regulation, 8 NYCRR §63.6, sets the baseline for acquisition recordkeeping independent of the federal minimums. Under §63.6(c)(6), records of the receipt and disposition of all drugs and/or devices must be maintained for five years — a longer floor than the two-year federal minimum for ordinary purchase invoices under 21 CFR 1304.04. Records must be kept in a retrievable form for Board and Department review, and if kept electronically, the system must be capable of producing a sortable, unaltered audit trail. Because the five-year NYCRR rule exceeds the federal two-year default, a New York pharmacy must retain acquisition records for the longer New York period even where federal law alone would permit disposal sooner.

Wholesaler Licensure and the Duty to Verify

A New York pharmacy may not simply buy from anyone claiming to be a wholesaler. Under Education Law Article 137, drug wholesalers must be registered with the NYS Board of Pharmacy; the DOH-4330 application package for a BNE license explicitly requires distributor-class applicants to submit a "Copy of NYS Board of Pharmacy registration as a Wholesaler," confirming that wholesaler registration is a distinct, checkable credential rather than something to assume from a plausible-looking invoice. If the wholesaler distributes controlled substances, it must additionally hold a DOH BNE Class 2 (in-state) or Class 2A (out-of-state) Distributor license under PHL Article 33 and 10 NYCRR Part 80 — and, because only Class 3A (Institutional Dispenser, Limited) licensees are exempt from the parallel federal requirement, the distributor must also carry the equivalent DEA registration. The Class 2/2A licensing fee is $1,200 for a new application and $250 for renewal.

Practically, this means the PIC (or a delegated buyer) should confirm, before placing a first order and periodically thereafter, that a prospective supplier's NYS BOP wholesaler registration and, if controlled substances are involved, its BNE Class 2/2A license and DEA registration are current. This is New York's counterpart to the federal DSCSA "authorized trading partner" concept covered in the federal supply-chain chapter: buying from an unregistered wholesaler exposes the pharmacy to disciplinary action even if the individual shipment otherwise looks legitimate.

Reverse Distribution and Returns

Outdated or recalled controlled-substance stock returned to a reverse distributor is itself a licensed activity in New York — DOH BNE Class 2R (Reverse Distributor) — though it carries no license fee. As with ordinary distribution, the receiving or returning pharmacy should document the return (product, quantity, date, and destination) in its acquisition/disposition records, consistent with the five-year retention rule under §63.6(c)(6).

Records & Retention Table

Exam Traps

• "Does a New York pharmacy need to separately confirm a supplier's wholesaler registration before the first order?" — Yes; NYS BOP wholesaler registration (and BNE distributor licensure/DEA registration for controlled substances) is a distinct, verifiable credential.
• "How long must ordinary (non-controlled) drug receipt records be kept in New York?" — Five years under 8 NYCRR §63.6(c)(6), not the two-year federal invoice minimum.
• "Is there a license fee for a Class 2R Reverse Distributor?" — No; Class 2R carries no BNE license fee, unlike the $1,200 new-application fee for an ordinary Class 2 Distributor.